Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel

By I. Bogoch, A. Watts, Andrea Thomas-Bachli, C. Huber, M. Kraemer, K. Khan. Journal of Travel Medicine, 2020

850 citations recorded by the source corpus.

Abstract There is currently an outbreak of pneumonia of unknown aetiology in Wuhan, China. Although there are still several unanswered questions about this infection, we evaluate the potential for international dissemination of this disease via commercial air travel should the outbreak continue.

Subfields: Infectious Diseases, Modeling and Simulation, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/59d73093e77a7636d94a53c4db52a654b8b6209a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. Annelies Wilder-Smith
2. Abdo A. Elfiky

In Modeling and Simulation

1. Jianhong Wu
2. Chris P. Jewell
3. Abdo A. Elfiky
4. Xingfu Zou
5. Wan-Tong Li
6. Guo Lin
7. Shigui Ruan
8. Jianhua Huang

In Public Health, Environmental and Occupational Health

1. Yanni Xiao
2. Annelies Wilder-Smith
3. Jianhong Wu
4. Sanyi Tang
5. Abdo A. Elfiky
6. Xingfu Zou
7. Wan-Tong Li
8. Guo Lin

Citations in the corpus

• Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions (2020, background): “According to our model, we get the exposed fraction as of 22 January 2020: approximately 40,000 persons from Wuhan to Beijing via trains (around 37,000) and flights (around 3000) [25], then, we have: Ime(t) = 40,000 · E(t)/N (4)”
• SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective (2020, background): “Late in December 2019, a rapid outbreak of a mysterious coronavirus, identified later as SARS-CoV-2, emerged in the city of Wuhan, China (Bogoch et al., 2020; Hui et al., 2020; Rothan & Byrareddy, 2020).”
• Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study (2020, background): “According to the World Health Organization (WHO) surveillance draft in January 2020, any traveler to Wuhan City in Hubei Province 2 weeks before the onset of the symptoms is suspected to be infected with COVID-19 (Bogoch et al., 2020 , Organization, 2020c .”
• Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions (2020, background): “2% of bookings, Jan 2017), Wuhan is connected internationally through both direct and indirect flights (Bogoch et al. 2020).”
• A brief review of socio-economic and environmental impact of Covid-19 (2020, background): “After an initial struggle to come up with the correct preventive measure, China has limited international arrivals to combat the pandemic (Bogoch et al. 2020).”
• Can we contain the COVID-19 outbreak with the same measures as for SARS? (2020, background): “33, 34 A second explanation might be that the infectious period is different.”
• Digital technologies in the public-health response to COVID-19 (2020, background): “Several systems have claimed detection of early disease reports for COVID-19, through the use of crowd-sourced data and news reports, before the WHO released a statement about the outbreak 14,20,26 .”